Dyadic International
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYAI and other ETFs, options, and stocks.About DYAI
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines.
CEOMark A. Emalfarb
CEOMark A. Emalfarb
Employees6
Employees6
HeadquartersJupiter, Florida
HeadquartersJupiter, Florida
Founded1987
Founded1987
Employees6
Employees6
DYAI Key Statistics
Market cap32.32M
Market cap32.32M
Price-Earnings ratio-3.79
Price-Earnings ratio-3.79
Dividend yield—
Dividend yield—
Average volume151.34K
Average volume151.34K
High today—
High today—
Low today—
Low today—
Open price$0.90
Open price$0.90
Volume0.00
Volume0.00
52 Week high$2.20
52 Week high$2.20
52 Week low$0.711
52 Week low$0.711
Stock Snapshot
Dyadic International(DYAI) stock is priced at $0.90, giving the company a market capitalization of 32.32M. It carries a P/E multiple of -3.79.
On 2025-12-18, Dyadic International(DYAI) stock opened at $0.90, reached a high of —, and a low of —.
The Dyadic International(DYAI)'s current trading volume is 0, compared to an average daily volume of 151.34K.
In the last year, Dyadic International(DYAI) shares hit a 52-week high of $2.20 and a 52-week low of $0.71.
In the last year, Dyadic International(DYAI) shares hit a 52-week high of $2.20 and a 52-week low of $0.71.
DYAI News
TipRanks 3d
Dyadic International establishes commercial partnership with OpesDyadic Applied BioSolutions has entered into a commercial agreement with Opes Diagnosticsto support the commercial launch of Dyadic’s recombinant human transfer...
People also own
Based on the portfolios of people who own DYAI. This list is generated using Robinhood data, and it’s not a recommendation.